Physician profile
Anne Moore
NPI 1285039156
$5,520.46
in general payments reported to CMS, 2019-2025
11 companies · $4,670 in 2025
The $4,670 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $205 · 2022: $236 · 2023: $88.88 · 2024: $320 · 2025: $4,670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,573 · Food and Beverage: $506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,573.00 |
| Food and Beverage | $506.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $4,635.03 | 2025 | |
| Medacta USA, INC. | $473.20 | 2021-2025 | Spherika, Mpact, Gmk Sphere |
| Vertos Medical, INC. | $135.91 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $125.96 | 2021-2024 | Zilretta, Iovera, Exparel |
| Smith+Nephew, INC. | $44.80 | 2021 | |
| Zimmer Biomet Holdings, INC. | $20.02 | 2022 | |
| Tela Bio, INC. | $19.40 | 2021 | |
| Pacira Therapeutics, INC. | $18.70 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $17.73 | 2024 | |
| Heraeus Medical, LLC. | $16.85 | 2022 | |
| Bioventus LLC | $12.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.